DuoPlavin clopidogrel/acetylsalicylic acid regulatory update

EMEA said Bristol-Myers and sanofi-aventis withdrew an MAA for DuoPlavin clopidogrel/acetylsalicylic acid to prevent atherothrombotic events in acute coronary syndrome (ACS) patients. The partners tol...